Skip to main content Skip to footer
American Family Children's Hospital
Erik A. Ranheim, MD, PhD close
Erik A. Ranheim, MD, PhD

New Patients

Need help selecting a primary care doctor? Contact the Welcome Center for personal assistance.

For Referring Physicians

How to refer a patient

Erik A. Ranheim, MD, PhD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Erik A. Ranheim, MD, PhD, earned his medical degree from the University of Minnesota and completed his residency at the Stanford University School of Medicine.




University Hospital
(608) 263-8437 | (800) 323-8942 | Map

Hospital Affiliation(s)

University Hospital
Veterans Hospital - Wm. S. Middleton Memorial

UW School of Medicine and Public Health

Department of Pathology and Laboratory Medicine

Professional Certifications and Education

Board Certification Hematopathology
Anatomic Pathology
Fellowship Stanford University School of Medicine, Stanford, CA
Residency Stanford University School of Medicine, Stanford, CA

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
PubMed Articles
Romero-Masters JC Ohashi M Djavadian R Eichelberg MR Hayes M Bristol JA Ma S Ranheim EA Gumperz J Johannsen EC Kenney SC An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. PLoS Pathog . 2018 Aug 20;14(8):e1007221
[PubMed ID: 30125329]
Albertini MR Yang RK Ranheim EA Hank JA Zuleger CL Weber S Neuman H Hartig G Weigel T Mahvi D Henry MB Quale R McFarland T Gan J Carmichael L Kim K Loibner H Gillies SD Sondel PM Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma. Cancer Immunol Immunother . 2018 Aug 3;
[PubMed ID: 30073390]
Brooks EG Thornton JM Ranheim EA Fabry Z Incorporation of autopsy case-based learning into PhD graduate education: a novel approach to bridging the "bench-to-bedside" gap. Hum Pathol . 2017 Oct;68:1-6
[PubMed ID: 28315694]
Mehta C Johnson KD Gao X Ong IM Katsumura KR McIver SC Ranheim EA Bresnick EH Integrating Enhancer Mechanisms to Establish a Hierarchical Blood Development Program. Cell Rep . 2017 Sep 19;20(12):2966-2979
[PubMed ID: 28930689]
Olson BM Bradley ES Sawicki T Zhong W Ranheim EA Bloom JE Colluru VT Johnson LE Rekoske BT Eickhoff JC McNeel DG Safety and Immunological Efficacy of a DNA Vaccine Encoding the Androgen Receptor Ligand-Binding Domain (AR-LBD). Prostate . 2017 May;77(7):812-821
[PubMed ID: 28181678]
Chang YI Kong G Ranheim EA Tu PS Yu YS Zhang J <i>Dnmt3a</i> haploinsufficiency cooperates with oncogenic <i>Kras</i> to promote an early-onset T-cell acute lymphoblastic leukemia. Am J Transl Res . 2017;9(3):1326-1334
[PubMed ID: 28386358]
Ma SD Tsai MH Romero-Masters JC Ranheim EA Huebner SM Bristol JA Delecluse HJ Kenney SC Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential. J Virol . 2017 Apr 1;91(7)
[PubMed ID: 28077657]
Zhang J Kong G Rajagopalan A Lu L Song J Hussaini M Zhang X Ranheim EA Liu Y Wang J Gao X Chang YI Johnson KD Zhou Y Yang D Bhatnagar B Lucas DM Bresnick EH Zhong X Padron E Zhang J p53-/- synergizes with enhanced NrasG12D signaling to transform megakaryocyte-erythroid progenitors in acute myeloid leukemia. Blood . 2017 Jan 19;129(3):358-370
[PubMed ID: 27815262]
Albertini MR Ranheim EA Zuleger CL Sondel PM Hank JA Bridges A Newton MA McFarland T Collins J Clements E Henry MB Neuman HB Weber S Whalen G Galili U Phase I study to evaluate toxicity and feasibility of intratumoral injection of α-gal glycolipids in patients with advanced melanoma. Cancer Immunol Immunother . 2016 Aug;65(8):897-907
[PubMed ID: 27207605]
Brooks EG Paus AM Corliss RF Ranheim EA Enhancing preclinical year pathology exposure: the Angevine approach. Hum Pathol . 2016 Jul;53:58-62
[PubMed ID: 27016489]
Damnernsawad A Kong G Wen Z Liu Y Rajagopalan A You X Wang J Zhou Y Ranheim EA Luo HR Chang Q Zhang J Kras is Required for Adult Hematopoiesis. Stem Cells . 2016 Jul;34(7):1859-71
[PubMed ID: 26972179]
Gao X Wu T Johnson KD Lahvic JL Ranheim EA Zon LI Bresnick EH GATA Factor-G-Protein-Coupled Receptor Circuit Suppresses Hematopoiesis. Stem Cell Reports . 2016 Mar 8;6(3):368-82
[PubMed ID: 26905203]
Gertz R Longley BJ Bennett D Ranheim E Rajamanickam V Kawahara T Endo J Integrating virtual dermatopathology as part of formative and summative assessment of residents: a feasibility pilot study. J Cutan Pathol . 2015 Oct;42(10):779-81
[PubMed ID: 25990466]
Johnson KD Kong G Gao X Chang YI Hewitt KJ Sanalkumar R Prathibha R Ranheim EA Dewey CN Zhang J Bresnick EH Cis-regulatory mechanisms governing stem and progenitor cell transitions. Sci Adv . 2015 Sep;1(8):e1500503
[PubMed ID: 26601269]
Zhang J Ranheim EA Du J Liu Y Wang J Kong G Zhang J Deficiency of β Common Receptor Moderately Attenuates the Progression of Myeloproliferative Neoplasm in NrasG12D/+ Mice. J Biol Chem . 2015 Jul 31;290(31):19093-103
[PubMed ID: 26082490]
Swinnen LJ Li H Quon A Gascoyne R Hong F Ranheim EA Habermann TM Kahl BS Horning SJ Advani RH Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404). Br J Haematol . 2015 Jul;170(1):56-65
[PubMed ID: 25823885]
Chang YI Damnernsawad A Allen LK Yang D Ranheim EA Young KH Zhang J Kong G Wang J Liu Y Fu HY Yang CS Guo J Song H Zhang J Evaluation of allelic strength of human TET2 mutations and cooperation between Tet2 knockdown and oncogenic Nras mutation. Br J Haematol . 2014 Aug;166(3):461-5
[PubMed ID: 24697267]
Ranheim EA A novel program for clinical pathology training for residents emphasizing high-impact and attending-level learning opportunities. Hum Pathol . 2014 Feb;45(2):206-12
[PubMed ID: 24196188]
Yang RK Kalogriopoulos NA Rakhmilevich AL Ranheim EA Seo S Kim K Alderson KL Gan J Reisfeld RA Gillies SD Hank JA Sondel PM Intratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the hu14.18 antibody increases intratumoral CD8+ T and NK cells and improves survival. Cancer Immunol Immunother . 2013 Aug;62(8):1303-13
[PubMed ID: 23661160]
Wang J Kong G Liu Y Du J Chang YI Tey SR Zhang X Ranheim EA Saba-El-Leil MK Meloche S Damnernsawad A Zhang J Zhang J Nras(G12D/+) promotes leukemogenesis by aberrantly regulating hematopoietic stem cell functions. Blood . 2013 Jun 27;121(26):5203-7
[PubMed ID: 23687087]